Home LifestyleHealth Coronavirus vaccination begins in the United States
Survey shows that the rate of COVID-19 infection in England has declined.

Coronavirus vaccination begins in the United States

by YCPress

Washington, December 14 The United States launched coronavirus vaccination on the 14th. The first batch of people to be vaccinated are medical staff and groups living in long-term care institutions such as nursing homes.

That morning, Sandra Lindsay, a nurse in the intensive care unit of the Jewish Medical Center on Long Island, New York, was the first vaccinated, becoming the first vaccinated in New York State and one of the first vaccinated in the United States.

During the live video vaccination, Lindsay thanked all the front-line workers and those around the world for their tireless efforts to fight the epidemic. She said that she “feeled hope” today and was relieved that vaccination would “be the beginning of ending this very painful period in American history”.

New York Gov. Andrew Cuomo said the day that it was the dawn at the end of the tunnel, “but it was a long tunnel.”

On the 11th, the U.S. Food and Drug Administration approved the application for emergency authorization of the coronavirus vaccine jointly developed by Pfizer Pharmaceutical Co., Ltd.

and the German biotechnology company. This is the first coronavirus vaccine approved for emergency use in the United States and is allowed for use in people aged 16 and above.

Robert Redfield, director of the U.S. Centers for Disease Control and Prevention, signed the recommendation to use the vaccine on the 13th. In a statement, he said that the first batch of vaccinations is scheduled to start on the 14th, which is a further effort to protect the American people, mitigate the impact of the epidemic, and restore people’s lives and national normalcy.

The COVID-19 vaccine, jointly developed by Pfizer Pharmaceuticals and German biotechnology, is a messenger ribonucleic acid (mRNA) vaccine that can work against the spiny protein of the novel coronavirus.

The mid-term analysis of phase III clinical trials released by the two companies in November showed that the vaccine was more than 90% effective. The two companies said that it would take another two years to continue to collect data on the efficacy and safety of the vaccine.

This vaccine needs to be stored at minus 70 degrees Celsius.